heparin/atrophy

Lyen an sove nan clipboard la

Chwazi kalite sòt

Paj 1 soti nan 647 rezilta yo

Effect of heparin on tendon degeneration: an experimental study on rats.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

This study investigated the local effects of heparin on locally administered corticosteroid-induced experimental Achilles tendinitis. After performing Achilles degeneration, 28 rats were divided into two groups; one was treated with local heparin and the other with saline injections at 3 and 6-day

Low-molecular-weight heparin or dual antiplatelet therapy is more effective than aspirin alone in preventing early neurological deterioration and improving the 6-month outcome in ischemic stroke patients.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE Dual antiplatelet therapy (DAT) with clopidogrel and aspirin has been shown to confer greater protection against early neurological deterioration (END) and early recurrent ischemic stroke (ERIS) than aspirin alone in patients who have experienced an acute ischemic stroke. However, few

Low-molecular-weight heparin and early neurologic deterioration in acute stroke caused by large artery occlusive disease.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Patients with acute ischemic stroke and large artery occlusive disease (LAOD) have an increased risk for early neurologic deterioration (END) due to progressive stroke, early recurrent ischemic stroke(ERIS), or symptomatic intracranial cerebral hemorrhage(SICH). Low-molecular-weight

Low-molecular-weight heparin is more effective than aspirin in preventing early neurologic deterioration and improving six-month outcome.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND We evaluated the efficacy of low-molecular-weight heparin (LMWH) relative to aspirin in preventing early neurologic deterioration (END), venous thromboembolism (VTE), and outcomes at 6 months. METHODS Patients were randomly assigned to receive either subcutaneous enoxaparin 4000

Role of heparin-binding epidermal growth factor-like growth factor in light-induced photoreceptor degeneration in mouse retina.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE Although heparin-binding epidermal growth factor-like growth factor (HB-EGF) has been reported to have protective effects against various neuronal cell damage, its role in the retina has not been elucidated. Here, we investigated its role in light-induced photoreceptor degeneration using

His-384 allotypic variant of factor H associated with age-related macular degeneration has different heparin binding properties from the non-disease-associated form.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

A polymorphism in complement factor H has recently been associated with age-related macular degeneration (AMD), the leading cause of blindness in the elderly. A histidine rather than a tyrosine at residue position 384 in the mature protein increases the risk of AMD. Here, using a recombinant

Effect of heparin treatment on the expression and activity of different ion-motive P-type ATPase isoforms from mouse extensor digitorum longus muscle during degeneration and regeneration after Bothrops jararacussu venom injection.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Ca(2+) ions are essential to myonecrosis, a serious complication of snake envenomation, and heparin seems to counteract this effect. We investigated the effect of local injection of Bothrops jararacussu venom in mouse fast-twitch extensor digitorum longus (EDL) muscle, without or with heparin, on

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye

heparin/atrophy

Effect of heparin on tendon degeneration: an experimental study on rats.

Low-molecular-weight heparin or dual antiplatelet therapy is more effective than aspirin alone in preventing early neurological deterioration and improving the 6-month outcome in ischemic stroke patients.

Low-molecular-weight heparin and early neurologic deterioration in acute stroke caused by large artery occlusive disease.

Low-molecular-weight heparin is more effective than aspirin in preventing early neurologic deterioration and improving six-month outcome.

Role of heparin-binding epidermal growth factor-like growth factor in light-induced photoreceptor degeneration in mouse retina.

His-384 allotypic variant of factor H associated with age-related macular degeneration has different heparin binding properties from the non-disease-associated form.

Effect of heparin treatment on the expression and activity of different ion-motive P-type ATPase isoforms from mouse extensor digitorum longus muscle during degeneration and regeneration after Bothrops jararacussu venom injection.

An evaluation of heparin in the treatment of senile macular degeneration.

[Effect of heparin S linguettes on senile macular degeneration of the retina].

[TREATMENT OF SENILE MACULAR DEGENERATION OF THE RETINA WITH HEPARIN].

[Treatment of senile macular degeneration with heparin and bradilan].

[Senile macular degeneration. Treatment with heparin and its derivatives].

[HEPARIN THERAPY IN SENILE DEGENERATION AND MYOPIC AFFECTIONS OF THE MACULA LUTEA].

Evaluation of heparin therapy of senile macular degeneration.

Heparin treatment of senile macular degeneration.

Baz done ki pi konplè remèd fèy medsin te apiye nan syans